Mylepsinum en es it fr

Mylepsinum Brand names, Mylepsinum Analogs

Mylepsinum Brand Names Mixture

  • No information avaliable

Mylepsinum Chemical_Formula


Mylepsinum RX_link

Mylepsinum fda sheet

Mylepsinum msds (material safety sheet)

Mylepsinum MSDS

Mylepsinum Synthesis Reference

Boon et al., Brit. pat. 666,027 (1952 to I.C.I.)

Mylepsinum Molecular Weight

218.252 g/mol

Mylepsinum Melting Point

281.5 oC

Mylepsinum H2O Solubility

500 mg/L

Mylepsinum State


Mylepsinum LogP


Mylepsinum Dosage Forms

Tablet; Chewable tablets; Oral suspension

Mylepsinum Indication

For the treatment of epilepsy

Mylepsinum Pharmacology

Primidone is a barbiturate with anticonvulsant properties. Primidone, either alone or used concomitantly with other anticonvulsants, is indicated in the control of grand mal, psychomotor, and focal epileptic seizures. It may control grand mal seizures refractory to other anticonvulsant therapy. Primidone raises electro- or chemoshock seizure thresholds or alters seizure patterns in experimental animals. Primidone per se has anticonvulsant activity as do its two metabolites, phenobarbital and phenylethylmalonamide (PEMA). In addition to its anticonvulsant activity, Primidone potentiates that of phenobarbital in experimental animals.

Mylepsinum Absorption

90 to 100%

Mylepsinum side effects and Toxicity

No information avaliable

Mylepsinum Patient Information

Mylepsinum Organisms Affected

Humans and other mammals